Axcan Pharma Inc. - T.AXP- Profile

Home » Directory » Pharmaceuticals & Biotechnology » Axcan Pharma Inc. » Profile
Website: http://www.axcan.com

Phone: +1 450 467-5138
Address:
597 Laurier Blvd
Mont Saint-Hilaire, QUEBEC J3H 6C4
Company Description
Axcan Pharma Inc. The Group's principal activities are to develop, manufacture and distribute pharmaceutical products in the field of gastroenterology. The products of the Group are used in the treatment of a variety of gastrointestinal diseases and disorders. Products like ULTRASE and VIOKASE are used for the treatment of certain gastrointestinal symptoms. URSO 250 is used for the treatment of certain cholestatic liver diseases. SALOFAK and CANASA are used for the treatment of certain inflammatory bowel diseases. PHOTOFRIN is used for the treatment of certain types of gastrointestinal and other conditions. Apart from these, the Group also offers products like BASALJEL, COPTIN, HELISAL One STEP, LACTEOL, TRANSULOSE, TRANSITOL, TAGAMET, MUDOLIN, SALOFALK and AMPHOJEL. The Group operates in Canada, the United States, Europe and other foreign countries.
Key People
Chairman, President & Chief Executive Leon F. Gosselin
Executive Vice President & Chief Operating Officer David W. Mims
Vice President Finance & Chief Financial Officer Jean Vezina
Secretary Francois Painchaud

Related Business Topics
Breaking News
Reuters - November 05, 2009 3:19 PM
SAN FRANCISCO (Reuters) - Federal prosecutors have arrested nine more people in the Galleon Group insider-trading scandal. The following describes some of the trades and companies involved with the case, as outlined in the complaints: * Telecom equipment ...
Forbes.com - November 05, 2009 12:25 PM
Lawyers are paid to keep secrets. But like anyone else, the more valuable the information they're sitting on, the more likely they are to welsh on their promise of confidentiality and sell privileged information to the highest bidder. As a case in ...
Forbes.com - November 05, 2009 12:13 PM
Lawyers are paid to keep secrets. But like anyone else, the more valuable the information they're sitting on, the more likely they are to welsh on their promise of confidentiality and sell privileged information to the highest bidder. As a case in ...
New York Times - November 05, 2009 11:48 AM
imes™s Alex Berenson provides more details of this developing case. DealBook is updating this post with more documents from the case as we get them. Authorities said Thursday that they were charging 14 people, including former employees of the Galleon ...
New York Times - November 05, 2009 9:49 AM
aid Thursday that they were charging 14 people, including former employees of the Galleon Group, with insider trading connected to the private equity boom that crested in 2007. Seven of these individuals were arrested Thursday morning, including one in ...
CVS/pharmacy
Find a local CVS, shop our weekly circular, manage your prescriptions
www.CVS.com
Overview  |  Profile